Literature DB >> 21054758

Anti-obesity drugs: to be or not to be?

R V Dvorak, A M Sharma, A Astrup.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 21054758     DOI: 10.1111/j.1467-789X.2010.00828.x

Source DB:  PubMed          Journal:  Obes Rev        ISSN: 1467-7881            Impact factor:   9.213


× No keyword cloud information.
  5 in total

Review 1.  Tolerability and safety of the new anti-obesity medications.

Authors:  Vojtech Hainer; Irena Aldhoon-Hainerová
Journal:  Drug Saf       Date:  2014-09       Impact factor: 5.606

2.  Comparison of a very low-calorie-ketogenic diet with a standard low-calorie diet in the treatment of obesity.

Authors:  Basilio Moreno; Diego Bellido; Ignacio Sajoux; Albert Goday; Dolores Saavedra; Ana B Crujeiras; Felipe F Casanueva
Journal:  Endocrine       Date:  2014-03-04       Impact factor: 3.633

3.  Obesity treatment by very low-calorie-ketogenic diet at two years: reduction in visceral fat and on the burden of disease.

Authors:  Basilio Moreno; Ana B Crujeiras; Diego Bellido; Ignacio Sajoux; Felipe F Casanueva
Journal:  Endocrine       Date:  2016-09-13       Impact factor: 3.633

4.  Weight loss and dropout during a commercial weight-loss program including a very-low-calorie diet, a low-calorie diet, or restricted normal food: observational cohort study.

Authors:  Erik Hemmingsson; Kari Johansson; Jonas Eriksson; Johan Sundström; Martin Neovius; Claude Marcus
Journal:  Am J Clin Nutr       Date:  2012-09-18       Impact factor: 7.045

5.  Comparative efficiency and safety of pharmacological approaches to the management of obesity.

Authors:  Vojtech Hainer
Journal:  Diabetes Care       Date:  2011-05       Impact factor: 19.112

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.